Applying the functional independence measure to the assessment of patients with mucopolysaccharidosis
Abstract
Introduction:
The aim of the study is to assess the functional independence of a group of patients with mucopolysaccharidosis using the Functional Independence Measure as a tool that accomplishes this purpose.
Methods:
This is a cross-sectional study of patients with mucopolysaccharidosis. Our data was collected between June 2015 and July 2016. In addition to history of present illness and physical examination each study participant was asked to answer a questionnaire to specifically evaluate their functional independence using the Functional Independence Measure. The internal consistency of the Functional Independence Measure was assessed using Cronbach’s alpha coefficient.
Results:
We collected data on 20 patients with mucopolysaccharidosis. The average age was 10.8 (8.67-13.03) years, the average weight was 23.6 (19,91-27,37) kg and the average height was 1 (0.83-1.17) m. The most prevalent type of mucopolysaccharidosis in the study was type VI (n=14). The average total Functional Independence Measure score was 104.4 (97.61-111.19), the average for the Mobility domain was 73.50 (68.22-78.78) and the average for the Cognitive Function domain was 30.90 (28.68-33.13). The internal consistency of the entire questionnaire was 0.859, with values of 0.966 for the Mobility domain and 0.624 for the Cognitive Function domain.
Conclusion:
The lowest Functional Independence Measure scores were obtained in the following sub-domains: Self-care, Locomotion and Cognitive Function. The Functional Independence Measure questionnaire demonstrated internal consistency for the evaluation of functional independence in patients with mucopolysaccharidosis, being able to value all the affected sub-domains separately.
Authors
Downloads
Keywords
- Mucopolysaccharidosis
- evaluation
- function
- independence
- validation
References
Vairo F, Federhen A, Baldo G, Riegel M, Burin M, Leistner-Segal S, Giugliani R. Diagnostic and treatment strategies in mucopolysaccharidosis VI. Appl Clin Genet. 2015;8:245-55. https://doi.org/10.2147/TACG.S68650
Wolf DA, Banerjee S, Hackett PB, Whitley CB, McIvor RS,1 and Low WC. Gene Therapy for Neurologic Manifestations of Mucopolysaccharidoses. Expert Opin Drug Deliv. 2015;12(2):283-296. https://doi.org/10.1517/17425247.2015.966682
Guffon N, Heron B, Chabrol B, Feillet F, Montauban V and Valayannopoulos V. Diagnosis, quality of life, and treatment of patients with Hunter syndrome in the French healthcare system: a retrospective observational study. Orphanet J Rare Dis. 2015;10:43 https://doi.org/10.1186/s13023-015-0259-0
Guarany NR, Vanz AP, Wilke MVMB, Bender DD, Borges MD, Giugliani R, and Schwartz IVD, PhD. Mucopolysaccharidosis: Caregiver Quality of Life. Journal of Inborn Errors of Metabolism & Screening. 2016;1-7. https://doi.org/10.1177/2326409815613804
Needham M., Packman W., Quinn N. Health-related quality of life in patients with MPS II. J. Genet. Couns. 2015;24:635-644. https://doi.org/10.1007/s10897-014-9791-7
Morishita K, Petty RE. Musculoskeletal manifestations of mucopolysaccharidoses. Rheumatology 2011;50:19-25 https://doi.org/10.1093/rheumatology/ker397
Raluy-Callado M, Chen WH, Whiteman DA, Fang J, Wiklund I. The impact of Hunter syndrome (mucopolysaccharidosis type II) on health-related quality of life. Orphanet J Rare Dis. 2013;8:101. https://doi.org/10.1186/1750-1172-8-101
Wiklund I, Raluy-Callado M, Stull DE, Jangelind Y, Whiteman DAH, Chen WH. The Hunter Syndrome-Functional Outcomes for Clinical Understanding Scale (HS-FOCUS) Questionnaire: evaluation of measurement properties. Qual Life Res. 2013;22:875-884 https://doi.org/10.1007/s11136-012-0196-5
Wiklund I, Raluy-Callado M, Chen WH, Muenzer J, Fang J, Whiteman D. The Hunter Syndrome-Functional Outcomes for Clinical Understanding Scale (HS-FOCUS) Questionnaire: item reduction and further validation. Qual Life Res. 2014;23:2457-2462 https://doi.org/10.1007/s11136-014-0703-y
Guarany NG, Schwartzb IVD, Guarany FC, Giugliania R. Functional capacity evaluation of patients with mucopolysaccharidosis. J Ped Rehab Med 2012;5 37-46 https://doi.org/10.3233/PRM-2012-0194
Kato T, Kato Z, Kuratsubo I, Ota T, Orii T, Kondo N, Suzuki Y. Evaluation of ADL in patients with Hunter disease using FIM score. Brain & Development 2007;29:298-305. https://doi.org/10.1016/j.braindev.2006.08.015
Riberto M. Orientação funcional para utilização da MIF: medida de independência funcional (MIF para adultos). HCFMUSP. DMR. 21p.
Riberto M, Miyazaki MH; Jucá SSH, Sakamato H, Pinto PPN, Battistella LR. Validação da Versão Brasileira da Medida de Independência. Funcional, Acta Fisiatr. 2004;11(2): 72-76
Keith RA, Granger CV, Hamilton BB, Sherwin FS. The functional independence measure: a new tool for rehabilitation. Adv Clin Rehabil 1987;1:6-18.
Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-174. https://doi.org/10.2307/2529310
Matos MA, Prado A, Schenkel G, Barreto R, Acosta AX. Gasto energético na marcha em paciente com Mucopolissacaridose. Acta Ortop Bras, 2013; 21(2):116-9. https://doi.org/10.1590/S1413-78522013000200009
Matos MA, Barreto R, Acosta AX. Evaluation of motor response in mucopolysaccharidosis patients treated with enzyme replacement therapy. Ortop Traumatol Rehabil. 2013;15(5):389-93. https://doi.org/10.5604/15093492.1084240
Haddad FS, Jones DH, Vellodi A, Kane N, Pitt MC.Carpal tunnel syndrome in the mucopolysaccharidoses and mucolipidoses. J Bone Joint Surg Br. 1997;79(4):576-82. https://doi.org/10.1302/0301-620X.79B4.0790576
Aslam R, , Hendriksz CJ, Jester A. Subjective and Objective Assessment of Hand Function in Mucopolysaccharidosis IVa Patients. JIMD Rep 2013;9:59-65. https://doi.org/10.1007/8904_2012_179
Hobart JC, Lamping DL, Freeman JA, Langdon DW, McLellan DL, Greenwood RJ, Thompson AJ. Evidence-based measurement: which disability scale for neurologic rehabilitation? Neurology. 2001;57(4):639-44. https://doi.org/10.1212/WNL.57.4.639
Copyright (c) 2020 Marcos Almeida Matos, Paloma Silva Lopes, Allan Rodrigues Corsini, Julia Rodi, Chin-To Fong (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The copy rights of the articles published in Colombia Médica belong to the Universidad del Valle. The contents of the articles that appear in the Journal are exclusively the responsibility of the authors and do not necessarily reflect the opinions of the Editorial Committee of the Journal. It is allowed to reproduce the material published in Colombia Médica without prior authorization for non-commercial use
